FAM
CAPR icon

Fred Alger Management’s Capricor Therapeutics CAPR Stock Holding History

Fred Alger Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,793
Closed -$2.33M – 455
2025
Q4 		$2.33M Buy
+80,793
New +$1.06M 0.01% 301
2024
Q4 		– Sell
-26,241
Closed -$399K – 422
2024
Q3 		$399K Buy
+26,241
New +$130K ﹤0.01% 387

Other funds holding CAPR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JHC
Jones Hill Capital New York $470M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Fred Alger Management's CAPR Position: Q1 2026 in Review

Fred Alger Management sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 80,793 shares — an estimated $2.33M sold.

Fred Alger Management first reported a position in CAPR in Q3 2024 and held it in 2 quarters. The position peaked at $2.33M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Fred Alger Management reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Fred Alger Management sold 80,793 Capricor Therapeutics shares in Q1 2026, an estimated $2.33M.
  • Fred Alger Management first reported a position in Capricor Therapeutics in Q3 2024 and held it in 2 quarters.
  • Fred Alger Management's Capricor Therapeutics position peaked at $2.33M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.